Skip to main content
Log in

Effects of Ketanserin on Systemic and Regional Haemodynamics in Patients with Essential Hypertension

  • Short Communication
  • Poster Presentations: Clinical Pharmacology
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Ando K, Fujita T, Ito Y, Noda H, Yamashita K. The role of renal haemodynamics in the antihypertensive effect of Captopril. American Heart Journal 111: 347–352, 1986

    Article  CAS  PubMed  Google Scholar 

  • Fagard R, Fiocchi R, Lijnen P, Staessen J, Moerman E, et al. Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension. British Heart Journal 51: 149–156, 1984

    Article  CAS  PubMed  Google Scholar 

  • Fujita T, Ando K, Noda H, Sato Y, Yamashita N, et al. Hemodynamic and endocrine changes associated with Captopril in diuretic-resistant hypertensive patients. American Journal of Medicine 73: 341–347, 1982

    Article  CAS  PubMed  Google Scholar 

  • Fujita T, Ito Y, Noda H, Sato Y, Ando K, et al. Vasodilatory actions of α-human atrial natriuretic peptide and high Ca2+ effects in normal man. Journal of Clinical Investigation 80: 832–840, 1987

    Article  CAS  PubMed  Google Scholar 

  • Kobrin I, Amodeo C, Ventura HO, Messerli FH, Frohlich ED. Immediate hemodynamic effects of Urapidil in patients with essential hypertension. American Journal of Cardiology 55: 722–725, 1985

    Article  CAS  PubMed  Google Scholar 

  • Robertson JIS, Stott DJ, Ball SG. Antihypertensive mode of action of ketanserin. Journal of Cardiovascular Pharmacology 10(Suppl. 3): S45–S47, 1987

    CAS  PubMed  Google Scholar 

  • Vanhoutte PM. 5-hydroxytryptamine and vascular disease. Federation Proceedings 42: 233–237, 1983

    CAS  PubMed  Google Scholar 

  • Vanhoutte PM, Van Nueten JM, Symoens J, Janssen PAJ. Antihypertensive properties of ketanserin (R 41 468). Federation Proceedings 42: 182–185, 1983

    CAS  PubMed  Google Scholar 

  • Van Nueten JM, Janssen PAJ, Symoens J, Janssen WJ, Heykants J, et al. Ketanserin. In Scriabine A (Ed.) New cardiovascular drugs, pp. 1–56, Raven Press, New York, 1987

    Google Scholar 

  • Wenting GJ, Man in’t Veld AJ, Woittiez AJ, Boomsma F, Schalekamp MADH. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. British Medical Journal 284: 537–539, 1982

    Article  CAS  PubMed  Google Scholar 

  • Wenting GJ, Woittiez AJJ, Man in’t Veld AJ, Schalekamp MADH. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109, 1984

    Article  CAS  PubMed  Google Scholar 

  • Woittiez AJJ, Wenting GJ, Van den Meiracker AH, Ritsema van Eck HJ, Man in’t Veld AJ, et al. Chronic effect of ketanserin in mild to moderate essential hypertension. Hypertension 8: 167–173, 1986

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, Y., Isaka, M., Noda, H. et al. Effects of Ketanserin on Systemic and Regional Haemodynamics in Patients with Essential Hypertension. Drugs 36 (Suppl 1), 120–122 (1988). https://doi.org/10.2165/00003495-198800361-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800361-00023

Keywords

Navigation